There are 784 resources available
GU (prostate, bladder)
Presenter: Melvin Lee Kiang Chua
Session: Technical aspects of radiation planning based on case discussion
Resources:
Presentation
Webcast
Sarcoma
Presenter: Angela Hong
Session: Technical aspects of radiation planning based on case discussion
Resources:
Presentation
Webcast
Non-hematological toxicity and timing of B12/Folate supplementation in NSCLC patients on pemetrexed based chemotherapy: Secondary analysis of the PEMVITASTART randomized trial (417O)
Presenter: Milind Baldi
Session: Thoracic malignancies 2
Resources:
Abstract
Presentation
Webcast
A multicenter study of noninvasive genotyping and dynamic monitoring of ROS1+NSCLC receiving treatment with crizotinib by next generation sequencing (418O)
Presenter: Wenxian Wang
Session: Thoracic malignancies 2
Resources:
Abstract
Safety of alectinib in non-small cell lung cancer patients with RET fusion gene (ALL-RET): results from the dose-finding portion of a phase 1/2 study (419O)
Presenter: Kaname Nosaki
Session: Thoracic malignancies 2
Resources:
Abstract
Presentation
Webcast
EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs) (420O)
Presenter: Ross Soo
Session: Thoracic malignancies 2
Resources:
Abstract
Presentation
Webcast
The heterogeneity of PD-L1 expression among the different histological components and metastatic lymph nodes in patients with resected lung adenosquamous carcinoma (396O)
Presenter: Yiwei Liu
Session: Thoracic malignancies 2
Resources:
Abstract
Antitumoral Effect of Low Molecular Weight Heparin in Localized Lung Cancer. A randomized phase III controlled trial (397O)
Presenter: Benjamin Besse
Session: Thoracic malignancies 2
Resources:
Abstract
Presentation
Webcast
Comprehensive Genomic Profiling (CGP) of 114,200 Advanced Cancers Identifies Recurrent Kinase Domain Duplications (KDD) and Novel Oncogenic Fusions in Diverse Tumor Types (1O)
Presenter: Sadakatsu Ikeda
Session: Proffered paper session 4
Resources:
Abstract
Presentation
Webcast
Prognostic gene expression signature in chemotherapy treated patients from the MAGIC trial (193O)
Presenter: Elizabeth Smyth
Session: Proffered paper session 4
Resources:
Abstract
Presentation
Webcast